Home/Filings/4/0000899243-18-031718
4//SEC Filing

MAGRAB E. BRENDAN 4

Accession 0000899243-18-031718

CIK 0001042418other

Filed

Dec 25, 7:00 PM ET

Accepted

Dec 26, 5:15 PM ET

Size

4.7 KB

Accession

0000899243-18-031718

Insider Transaction Report

Form 4
Period: 2018-12-20
MAGRAB E. BRENDAN
DirectorChairman of the Board
Transactions
  • Award

    Common Stock

    2018-12-20$0.08/sh+65,000$5,20065,000 total

Issuer

HedgePath Pharmaceuticals, Inc.

CIK 0001042418

Entity typeother

Related Parties

1
  • filerCIK 0001196062

Filing Metadata

Form type
4
Filed
Dec 25, 7:00 PM ET
Accepted
Dec 26, 5:15 PM ET
Size
4.7 KB